Co-administration can cause severe, prolonged hypertension. Monitor for hypertension if norepinephrine bitartrate cannot be avoided.
Source: NLP:norepinephrine bitartrate
10 interactions on record
Co-administration can cause severe, prolonged hypertension. Monitor for hypertension if norepinephrine bitartrate cannot be avoided.
Source: NLP:norepinephrine bitartrate
CYP2D6 substrate antidepressant. Bupropion inhibits CYP2D6, increasing nortriptyline exposure. Dose reduction may be necessary.
Source: NLP:bupropion hcl er (xl)
CYP2D6-metabolized antidepressant. Bupropion inhibits CYP2D6 and can increase nortriptyline concentrations. Consider dose reduction.
Source: NLP:bupropion hydrochloride
Dosage adjustment of nortriptyline may be necessary when used concomitantly with divalproex sodium delayed-release tablets.
Source: NLP:divalproex sodium
Concomitant use may potentiate the cardiovascular effects of dopamine, including hypertension.
Source: NLP:dopamine hydrochloride
Fluconazole increases the effect of nortriptyline. Dosage adjustment may be necessary; monitor plasma levels.
Source: NLP:fluconazole
Paroxetine is a strong CYP2D6 inhibitor that may increase nortriptyline concentrations. Use caution and monitor.
Source: NLP:paroxetine
Rifampin increases metabolism of nortriptyline, requiring higher than expected doses; discontinuation causes nortriptyline levels to rise.
Source: NLP:rifampin
Dosage adjustment of nortriptyline may be necessary if used concomitantly with valproate due to altered pharmacokinetics.
Source: NLP:valproate sodium
Dosage adjustment may be necessary if used concomitantly with valproic acid.
Source: NLP:valproic acid